Publications:

Expression and prognosis analysis of TET family in acute myeloid leukemia.

Aging

Zhang, Tingjuan T; Zhao, Yangli Y; Zhao, Yangjing Y; Zhou, Jingdong J

Publication Date: 2020-03-25

Variant appearance in text: TET2: Q831H

PubMed Link: 32209730

Variant Present in the following documents:

• aging-12-102928-s004..xlsx, sheet 2

View BVdb publication page

Molecular basis of targeted therapy in T/NK-cell lymphoma/leukemia: A comprehensive genomic and immunohistochemical analysis of a panel of 33 cell lines.

Plos One

Mondejar, Rufino R; Pérez, Cristina C; Onaindia, Arantza A; Martinez, Nerea N; González-Rincón, Julia J; Pisonero, Helena H; Vaqué, Jose Pedro JP; Cereceda, Laura L; Santibañez, Miguel M; Sánchez-Beato, Margarita M; Piris, Miguel Angel MA

Publication Date: 2017

Variant appearance in text: TET2: 2493G>T; Gln831His

PubMed Link: 28505169

Variant Present in the following documents:

• pone.0177524.s006.xlsx, sheet 1

View BVdb publication page

A Landscape of Pharmacogenomic Interactions in Cancer.

Cell

Iorio, Francesco F; Knijnenburg, Theo A TA; Vis, Daniel J DJ; Bignell, Graham R GR; Menden, Michael P MP; Schubert, Michael M; Aben, Nanne N; Gonçalves, Emanuel E; Barthorpe, Syd S; Lightfoot, Howard H; Cokelaer, Thomas T; Greninger, Patricia P; van Dyk, Ewald E; Chang, Han H; de Silva, Heshani H; Heyn, Holger H; Deng, Xianming X; Egan, Regina K RK; Liu, Qingsong Q; Mironenko, Tatiana T; Mitropoulos, Xeni X; Richardson, Laura L; Wang, Jinhua J; Zhang, Tinghu T; Moran, Sebastian S; Sayols, Sergi S; Soleimani, Maryam M; Tamborero, David D; Lopez-Bigas, Nuria N; Ross-Macdonald, Petra P; Esteller, Manel M; Gray, Nathanael S NS; Haber, Daniel A DA; Stratton, Michael R MR; Benes, Cyril H CH; Wessels, Lodewyk F A LFA; Saez-Rodriguez, Julio J; McDermott, Ultan U; Garnett, Mathew J MJ

Publication Date: 2016-07-28

Variant appearance in text: TET2: 2493G>T; Q831H

PubMed Link: 27397505

Variant Present in the following documents:

• mmc3.xlsx, sheet 3

View BVdb publication page

Hypermethylation of the alternative AWT1 promoter in hematological malignancies is a highly specific marker for acute myeloid leukemias despite high expression levels.

Journal Of Hematology & Oncology

Guillaumet-Adkins, Amy A; Richter, Julia J; Odero, Maria D MD; Sandoval, Juan J; Agirre, Xabi X; Catala, Albert A; Esteller, Manel M; Prósper, Felipe F; Calasanz, María José MJ; Buño, Ismael I; Kwon, Mi M; Court, Franck F; Siebert, Reiner R; Monk, David D

Publication Date: 2014-01-09

Variant appearance in text: TET2: Q831H

PubMed Link: 24405639

Variant Present in the following documents:

• Main text
• 1756-8722-7-4.pdf

View BVdb publication page